US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.570
  • -0.110-2.99%
Close Jul 19 16:00 ET
300.68MMarket Cap-1830P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atea Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.75

-74.42%
Analyst Rating

Sell

Jul 21, 2024

Atea Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Feb 28, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Feb 28, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Atea Pharmaceuticals Earnings Reports

  • Atea Pharmaceuticals | 10-Q: Quarterly report

    May 14 16:47 ET

  • Atea Pharmaceuticals | 10-K: Annual report

    Feb 28 22:56 ET

  • Atea Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 16:43 ET

  • Atea Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:46 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 21, 2024

    Sell

    • Buy

      0.00%

    • Hold

      0.00%

    • Sell

      100.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg